Minghui Pharmaceutical (hangzhou) Ltd

This is the first study in people to test a new drug called MHB009C for patients with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see how the body processes the drug, while also looking for early signs that it m…

This study is testing whether a new injection called MHB018A can safely reduce eye bulging and other symptoms in people with long-term, moderate-to-severe Thyroid Eye Disease. About 150 participants will receive either the real injection or a placebo dummy shot every four weeks f…

This study is the next step for people who were in earlier trials for Thyroid Eye Disease (TED). It aims to see if a long-term injection called MHB018A can safely reduce eye bulging and other symptoms. It is specifically for people who did not get enough benefit from the placebo …